ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,860, issued on July 14, was assigned to UNIVERSITY OF KANSAS (Lawrence, Kan.).

"C-terminal HSP90 inhibitors" was invented by Brian S.J. Blagg (Lawrence, Kan.), Bhaskar Reddy Kusuma (Lake Ronkonkoma, N.Y.) and Teather Sundstrom (Eckelson, N.D.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Hsp90 C-terminal inhibitors and pharmaceutical compositions containing such compounds are provided. The compounds of the disclosure are useful for the treatment and/or prevention of neurodegenerative disorders such as diabetic peripheral neuropathy."

The patent was filed on May 17, 2024, under Application No. 18/667,496.

*For further information, including images...